Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Pheochromocytoma × pegfilgrastim × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Breast Neoplasms 3 Sarcoma 2 Sarcoma, Synovial 1 Pheochromocytoma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lymphoma 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Fibrosarcoma 1 Breast Neoplasms, Male 1

Interventions

pegfilgrastim 1 Stem Cell Transplantation 1 Saline Solution 1 Granulocyte Colony-Stimulating Factor 1 Dexmedetomidine 1 Cryosurgery 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01850888 2025-12-18

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Masonic Cancer Center, University of Minnesota

Phase NA Completed

Neuroblastoma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡